This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2008 Summer;11(3):179-82.

doi: 10.1111/j.1751-7141.2008.07766.x.

ENHANCE and ONTARGET

Philip R Liebson¹

Affiliations

PMID: 18612263
DOI: 10.1111/j.1751-7141.2008.07766.x

Free article

Review

ENHANCE and ONTARGET

Philip R Liebson. Prev Cardiol. 2008 Summer.

Free article

. 2008 Summer;11(3):179-82.

doi: 10.1111/j.1751-7141.2008.07766.x.

Author

Philip R Liebson¹

Affiliation

¹ Rush University Medical Center, 1653 West Congress Parkway, Chicago, IL 60612, USA. pliebson@rush.edu

PMID: 18612263
DOI: 10.1111/j.1751-7141.2008.07766.x

No abstract available

PubMed Disclaimer

Comment on

Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, Visseren FL, Sijbrands EJ, Trip MD, Stein EA, Gaudet D, Duivenvoorden R, Veltri EP, Marais AD, de Groot E; ENHANCE Investigators. Kastelein JJ, et al. N Engl J Med. 2008 Apr 3;358(14):1431-43. doi: 10.1056/NEJMoa0800742. Epub 2008 Mar 30. N Engl J Med. 2008. PMID: 18376000 Clinical Trial.
Telmisartan, ramipril, or both in patients at high risk for vascular events.
ONTARGET Investigators; Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. ONTARGET Investigators, et al. N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31. N Engl J Med. 2008. PMID: 18378520 Clinical Trial.

Similar articles

Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in preventive cardiology: which drug to use and what to expect in light of the ONTARGET trial.
Cairns JA. Cairns JA. Pol Arch Med Wewn. 2008 Jun;118(6):335-8. Pol Arch Med Wewn. 2008. PMID: 18619187 No abstract available.
ONTARGET proves telmisartan efficacy compared to ramipril in cardiovascular protection of patients at high risk and without heart failure.
[No authors listed] [No authors listed] Cardiovasc J Afr. 2008 Mar-Apr;19(2):108-9; discussion 109-10. Cardiovasc J Afr. 2008. PMID: 18516357 No abstract available.
ASCOT - more than a horse race!
Kjeldsen SE, Narkiewicz K, Hedner T. Kjeldsen SE, et al. Blood Press. 2005;14(5):262-3. doi: 10.1080/08037050500350942. Blood Press. 2005. PMID: 16257870 No abstract available.
[Current and future medical therapies for CKD (chronic kidney disease)].
Maruyama S. Maruyama S. Nihon Yakurigaku Zasshi. 2008 Sep;132(3):166-72. doi: 10.1254/fpj.132.166. Nihon Yakurigaku Zasshi. 2008. PMID: 18787299 Review. Japanese. No abstract available.
Statins, ACE inhibitors and ARBs in cardiovascular disease.
Montecucco F, Mach F. Montecucco F, et al. Best Pract Res Clin Endocrinol Metab. 2009 Jun;23(3):389-400. doi: 10.1016/j.beem.2008.12.003. Best Pract Res Clin Endocrinol Metab. 2009. PMID: 19520311 Review.

See all similar articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Medical
- MedlinePlus Health Information